Commentary from locomotive engineer Jason Doering On Aug. 11, 2026, a federal appeals court upheld the Federal Railroad ...
Vera Therapeutics (VERA) stock jumped 4% after two-year ORIGIN3 trial data showed Trutakna slowed kidney decline to normal ...
Dominick Cebula had to fight the animal off twice before he was airlifted for medical treatment ...
Recent studies indicate that traveling can play a vital role in decelerating biological aging. Engaging in positive travel ...
The Short Duration Income ETF returned 1.17% in 2Q26, outperforming its benchmark. Read the full analysis for more details.
Global leading indicators stabilised over the summer, albeit at a weak level. The key question is whether the repricing in ...
The POLARIS-1 study enrolled 147 patients with uncontrolled, moderate-to-severe asthma, and the interim analysis was conducted on the first 98 patients. The analysis demonstrated a half-life of up to ...
Opus Genetics announced positive 3- and 6-month results from the low-dose cohort 1 of BIRD-1, the ongoing phase 1/2 ...
Asthma is one of the most prevalent chronic respiratory diseases, imposing a considerable individual and societal burden, yet objective diagnosis remains challenging. Diagnosis relies on several ...
playing video games might enhance the usage of declarative knowledge as well as hippocampal involvement and enhances overall ...
Discover 10 of the best games featured in Steam Programming Fest 2026, including programming puzzles, hacking simulators, automation games, and creative coding experiences.
Vietnam Investment Review on MSN
Kelun Biotech partner reports positive asthma Phase 2 trial results
CHENGDU, China, Sept. 8, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company") today announced that its partner, Windward Bio, has reported positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results